DWM
WST icon

Dakota Wealth Management’s West Pharmaceutical WST Stock Holding History

Dakota Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Buy
+32,568
New +$9.96M 0.22% 101
2025
Q3 		– Sell
-2,843
Closed -$622K – 800
2025
Q2 		$622K Buy
2,843
+4
+0.1% +$855 0.01% 477
2025
Q1 		$636K Buy
2,839
+776
+38% +$214K 0.01% 469
2024
Q4 		$676K Sell
2,063
-109
-5% -$34.3K 0.02% 442
2024
Q3 		$652K Buy
2,172
+141
+7% +$43.2K 0.01% 456
2024
Q2 		$669K Buy
2,031
+156
+8% +$55.1K 0.02% 451
2024
Q1 		$742K Buy
1,875
+84
+5% +$31.1K 0.02% 428
2023
Q4 		$631K Buy
1,791
+24
+1% +$8.49K 0.02% 385
2023
Q3 		$663K Sell
1,767
-16
-0.9% -$6.19K 0.03% 349
2023
Q2 		$682K Sell
1,783
-135
-7% -$48.2K 0.03% 321
2023
Q1 		$665K Buy
1,918
+96
+5% +$28.1K 0.04% 301
2022
Q4 		$429K Buy
1,822
+175
+11% +$41.5K 0.03% 381
2022
Q3 		$406K Buy
1,647
+237
+17% +$72.2K 0.03% 378
2022
Q2 		$426K Buy
+1,410
New +$459K 0.04% 310

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dakota Wealth Management's WST Position: Q2 2026 in Review

Dakota Wealth Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 32,568 shares worth $11.7M. The stake represents 0.22% of the portfolio and ranks #101 among its holdings. This is a return to the name: Dakota Wealth Management previously reported a position in WST as recently as Q2 2025.

Dakota Wealth Management first reported a position in WST in Q2 2022 and has held it in 14 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Dakota Wealth Management held 32,568 shares of West Pharmaceutical worth $11.7M as of Q2 2026.
  • West Pharmaceutical was a new Dakota Wealth Management position in Q2 2026.
  • West Pharmaceutical made up 0.22% of Dakota Wealth Management's portfolio in Q2 2026, its #101 holding.
  • Dakota Wealth Management first reported a position in West Pharmaceutical in Q2 2022 and has held it in 14 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.